Home / Pharmaceuticals / Nootropics Market By Applications (Memory Enhancement, Mood And Depression, Attention A nd Focus, Longevity And Anti-Aging, Sleep, Recovery And Dream Enhancement, Anxiety) - Growth, Future Prospects & Competitive Analysis, 2016 - 2023

Nootropics Market By Applications (Memory Enhancement, Mood And Depression, Attention A nd Focus, Longevity And Anti-Aging, Sleep, Recovery And Dream Enhancement, Anxiety) - Growth, Future Prospects & Competitive Analysis, 2016 - 2023

Published: Dec 2016 | Report Code: 58257-12-16

The purpose of this research study titled ‘Nootropics Market - Growth, Future Prospects, and Competitive Analysis, 2016 – 2024’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global nootropics products market. This report presents and analyzes the major trends prevalent in the global nootropics market and the market size and forecast.

Based on application types, this report studies the global nootropics market into memory enhancement, mood and depression, attention and focus, longevity and anti-aging, sleep, recovery and dream enhancement, and anxiety applications. Market size and forecast for each mentioned segment for the period 2014-2024 is presented in the report along with respective CAGRs for the forecast duration 2016-2024.

Geographically, the global nootropics market is best understood by segmenting the market into five major regions and chief country level markets as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Rest of Asia-Pacific
  • Middle East and Africa
  • Latin America

This report also includes qualitative assessment factors such as market dynamics (drivers, challenges and opportunities) to have a good understanding of the current and anticipated market trends. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players       are also presented in the study. This report also includes profiling of top 30 nootropics commercially available in the global market. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the market. Some of the key players profiled in this report are Nootrobox, Inc., Cephalon, Inc., Purelife Bioscience Co. Ltd., Peak Nootropics, Nootrico, SupNootropic Biological Technology Co. Ltd., AlternaScript LLC, Accelerated Intelligence, Inc., Onnit Labs LLC, Powder City LLC, Ceretropic, Nootropic Source, and Clarity Nootropics.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Nootropics Market Portraiture
2.2 Global Nootropics Market, by Type of Application, 2015 (USD Mn)
2.3 Global Nootropics Market Share, by Geography, 2015 (Value %)

Chapter 3 Nootropics Market Analysis
3.1 Global Nootropics Market Overview
3.2 Top 30 Drug Profiles
3.2.1 Adrafinil
3.2.2 Phenylpiracetam (Phenotropil)
3.2.3 Noopept
3.2.4 Sulbutiamine
3.2.5 Pramiracetam
3.2.6 Sunifiram
3.2.7 Piracetam
3.2.8 Oxiracetam
3.2.9 Aniracetam
3.2.10 Magnesium Citrate
3.2.11 Alpha- GPC
3.2.12 CDP-choline
3.2.13 Gynostemma
3.2.14 Ashwagandha
3.2.15 Bacopa Monnieri
3.2.16 Phenibut
3.2.17 Rhodila Rosea
3.2.18 Galantamine
3.2.19 Phenylethylamine (PEA)
3.2.20 Alpha-Lipoic Acid (ALA)
3.2.21 Uridine Monophosphate
3.2.22 Centrophenoxine
3.2.23 L-Dopa
3.2.24 N-Acetyl-Cysteine
3.2.25 L-theanine
3.2.26 Acetyl L-Cartinine
3.2.27 Huperzine A
3.2.28 Picamilon
3.2.29 Vinpocetine
3.2.30 Ginkgo Biloba
3.3 Market Dynamics
3.3.1 Market Drivers
3.3.1.1 Booming Supplements Industry
3.3.1.2 Sales Channel Proliferation
3.3.2 Challenges
3.3.2.1 Increase in Regulatory Pressures
3.3.3 Opportunities
3.3.3.1 Growth of E-commerce
3.4 Attractive Investment Proposition
3.5 Competitive Landscape of Key Players in Nootropics Market

Chapter 4 Global Nootropics Market Analysis, by Applications
4.1 Introduction
4.2 Memory Enhancement
4.3 Mood and Depression
4.4 Attention and Focus
4.5 Longevity and Anti-aging
4.6 Sleep, Recovery and Dream Enhancement
4.7 Anxiety

Chapter 5 Global Nootropics Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan and Rest of APAC)
5.5 Latin America
5.6 Middle East and Africa

Chapter 6 Company Profiles
6.1 Nootrobox, Inc.
6.2 Cephalon, Inc.
6.3 Purelife Bioscience Co. Ltd.
6.4 Peak Nootropics
6.5 Nootrico
6.6 SupNootropic Biological Technology Co. Ltd.
6.7 AlternaScript LLC
6.8 Accelerated Intelligence, Inc.
6.9 Onnit Labs LLC
6.10 Powder City LLC
6.11 Ceretropic
6.12 Nootropic Source
6.13 Clarity Nootropics

List Of Table :

TABLE 1 Market Positioning of Key Players in Global Nootropics Market
TABLE 2 Global Nootropics Market, by Application, 2014 – 2024 (USD Mn)
TABLE 3 Global Nootropics Market, by Geography, 2014 – 2024 (USD Mn)
TABLE 4 North America Nootropics Market, by Country, 2014 – 2024 (USD Mn)
TABLE 5 Europe Nootropics Market, by Country, 2014 – 2024 (USD Mn)
TABLE 6 Asia Pacific Nootropics Market, by Country, 2014 – 2024 (USD Mn)
TABLE 7 Nootrobox, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 8 Cephalon, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 9 Purelife Bioscience Co. Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 10 Peak Nootropics: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 11 Nootrico: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 12 SupNootropic Biological Technology Co., Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 13 AlternaScript LLC: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 14 Accelerated Intelligence, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 15 Onnit Labs LLC: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 16 Powder City LLC: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 17 Ceretropic: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 18 Nootropic Source: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 19 Clarity Nootropics: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)

List Of Figure :

FIG. 1 Nootropics Market: Research Methodology
FIG. 2 Global Nootropics Market, by Type of Application, 2015 (USD Mn)
FIG. 3 Global Nootropics Market Share, by Geography, 2015 (Value %)
FIG. 4 Attractive Investment Proposition: Global Nootropics Market, by Geography
FIG. 5 Global Nootropics for Memory Enhancement Market, 2014 – 2024 (USD Mn)
FIG. 6 Global Nootropics for Mood and Depression Market, 2014 – 2024 (USD Mn)
FIG. 7 Global Nootropics for Attention and Focus Market, 2014 – 2024 (USD Mn)
FIG. 8 Global Nootropics for Longevity and Anti-aging Market, 2013 – 2024 (USD Mn)
FIG. 9 Global Nootropics for Sleep, Recovery and Dream Enhancement Market, 2014 – 2024 (USD Mn)
FIG. 10 Global Nootropics for Anxiety Market, 2014 – 2024 (USD Mn)
FIG. 11 Latin America Nootropics Market, 2014 – 2024 (USD Mn)
FIG. 12 Middle East and Africa Nootropics Market, 2014 – 2024 (USD Mn)

The global nootropics market is studied for the following applications:

  • Memory Enhancement
  • Mood and Depression
  • Attention and Focus
  • Longevity and Anti-aging
  • Sleep, Recovery and Dream Enhancement
  • Anxiety

 Nootropics Market

Nootropics, or smart drugs comprise compounds that enhance brain function. These drugs are becoming increasingly popular in the developed world to give the mind an extra boost. Several nootropics claim promising benefits such as focus, motivation and boosting memory and there is research in place to support their specific claims. Yet, a majority of effective nootropics are not intended for use without prescription to treat a specific condition; moreover, recreational use of nootropics is highly debated among physicians and researchers. Among the application types, nootropics find the widest application in memory enhancement. Students, entrepreneurs, investment bankers, scientists, artists, and Silicon Valley incumbents are increasingly opting for memory enhancers to sharpen their minds in order to gain competitive edge. Memory enhancing nootropics augment learning capacity and information retention, resist disruption, increase brain functions and protect the brain form chemical harms. At present memory enhancing nootropics hold the largest market share due to growing awareness with respect to the promised benefits to students and working population.

Geographically, the global nootropics market is cumulative to North America, Europe, Asia-Pacific, Middle East and Africa and Latin America.

 Nootropics Market

In the base 2015, North America was observed as the largest market for nootropic drugs. The rising population, increased consumer awareness for preventive and cognitive healthcare, the rise of the self-directed consumer, and channel proliferation are the factors that drive the nootropics market in North America. Europe accounted for the second largest market for nootropic drugs. The market is driven by the substantial increase in the demand for cognitive healthcare products among the youths in the region. Asia Pacific is anticipated to the fastest growing nootropic market. The major reason being the population in the region supported by the favorable regulatory scenario in the region. Moreover, growth of emerging markets, interest in innovative delivery formats, consumer awareness regarding the benefits of nootropic drugs and new product availability are the major drivers for the market.

The detailed regional classification of the global nootropics market is as follows:

  • North America (U.S. & Canada)
  • Europe (U.K., Germany and Rest of Europe)
  • Asia-Pacific (Japan, China and Rest of Asia-Pacific)
  • Latin America
  • Middle East and Africa
Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients